Doisy, L., Cimier, A., Adypagavane, A., Walz, J., Marquette, T., Maubon, T., . . . Pignot, G. (2021). Efficacy of HIVEC in patients with high-risk non-muscle invasive bladder cancer who are contraindicated to BCG and in patients who fail BCG therapy. Taylor & Francis Group.
Chicago Style (17th ed.) CitationDoisy, Laure, et al. Efficacy of HIVEC in Patients with High-risk Non-muscle Invasive Bladder Cancer Who Are Contraindicated to BCG and in Patients Who Fail BCG Therapy. Taylor & Francis Group, 2021.
MLA (8th ed.) CitationDoisy, Laure, et al. Efficacy of HIVEC in Patients with High-risk Non-muscle Invasive Bladder Cancer Who Are Contraindicated to BCG and in Patients Who Fail BCG Therapy. Taylor & Francis Group, 2021.
Warning: These citations may not always be 100% accurate.